“Radiotherapy is used in 50% of cancer patients, but only 5% of funding goes towards radiotherapy research”. A challenge around the world. Congrats Anthony Chalmers 💙.

Rad Onc trainees in any stage and those who have graduated (🙋🏻‍♀️) will benefit from reviewing Nicholas Zaorsky, MD MS’s educational threads. Truly a gold mine!! docs.google.com/document/d/19y…

Single fraction RT (8Gy) significantly improves hepatic pain compared with best supportive care and can be considered standard palliative treatment. No increase in toxicity. Laura Dawson CCTG thelancet.com/journals/lanon…

Honored to be with this amazing team of mentees & faculty kicking off the in-person meeting at #WCLC24. Thank you chairs Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation Christian Rolfo Looking forward to exciting presentations from the mentees proudly displaying their work. RadOncUH Daniel E Spratt Rohan Patel, MD

Not a football fan? Check out the NRG Oncology Podcast instead, created to allow everyone to listen to topics regarding cancer care, trial barriers & a variety of other topics. Tune in and follow us on Spotify, Apple Podcasts, and YouTube. Stephen Chun @Lauren_Henke

ONE week away from our next "The NRG Oncology Podcast" episode! We sit w/ Dr. Mannel, NRG Group Chair & Director of the OU Health Stephenson Cancer Center to discuss #GynOnc, GYN health disparities & early career investigators OU Health Stephenson Cancer Center OU Health Stephen Chun Lauren Henke, MD, MSCI

Join us next week for a new NRG Oncology podcast with Dr. Robert Mannel on our Gyn/Onc program. Lauren Henke, MD, MSCI MD Anderson Cancer Center OU Health Case Western

Don’t forget to sign up for our second virtual meet and greet! Tomorrow, Wednesday, from 7-8p ET! Sign up here 👉🏼: forms.gle/2wZFqbLRQjeBAg… Can’t wait to see you there!! Angela Jia Lauren Henke, MD, MSCI

Pet Shop Boys better stay inside and lock the doors. You too Snoop Dogg. And Pitbull.

The Taylor Swift endorsement has landed.

PANDAS-PRODIGE 44 mFOLFIRINOX +/- chemoRT (50.4 Gy) in borderline resectable pancreas cancer. No dif in R0 resection (1 endpt) or OS for all comers…but pCR for chemoRT group was 29% (vs. 8%) & OS improved w chemoRT for pts undergoing resection (48 vs. 36 months). #ESMO24

RADIANT trial out now IJROBP - The Red Journal - In patients with oligoprogressive GU, breast & GI cancers treated with SBRT, >50% remain on same line systemic therapy at a year. More analyses to come Aisling Barry Joelle Radiation Medicine Program authors.elsevier.com/sd/article/S03…

⚙️⚙️⚙️TOPGEAR presented today at #ESMO24: Preop chemoRT increased pCR but did not improve PFS or OS, compared to periop chemo for gastric cancer. Huge congrats to Trevor Leung and colleagues for this important trial! ⬇️1/6

Lauren Henke, MD, MSCI and I will face-off on several hot topics and our vision for the future of adaptive radiotherapy at ASTRO #ASTRO2024 on 9-29 at 7-8 EST. This live debate will include audience participation! Register here: forms.office.com/Pages/Response…

Great session at #ESMO24 by Pedro C Barata, MD MSc FACP on optimal management strategies for non-clear cell #kidneycancer, covering a broad range of subtypes and stressing the need for more dedicated trials. #RCC OncoAlert ESMO - Eur. Oncology

It's #GynecologicCancer Awareness Month and we're ONE DAY away from "The NRG Oncology Podcast" episode 3 where we take a look at #GynOnc, GYN health disparities & early career investigators OU Health Stephenson Cancer Center OU Health Stephen Chun Lauren Henke, MD, MSCI #GynecologicCancerAwarenessMonth

Tune in TOMORROW to the #NRGoncologypodcast to hear Stephen Chun and my conversation with @robertmannel (he’s so full of great insights) about all things #gynonc, and what NRG Oncology is doing to move the needle for patients with gynecologic cancers 💫 💪🏼

To me this headline is excess risk of secondary sarcoma after RT in breast cancer patients with TP53 pathogenic mutations may be much lower than previously suggested. No difference in secondary cancers overall. #radonc

Can inhaled corticosteroid reduce RT induced lung damage during radical lung rt for unresectable IIIa/b?; n292; yes it can. 15% reduction in radiation pneumonitis. #ESMO24 lovely trial; practice changing #ESMO24

As we are treating more lesions with SABR, we need ways to quickly evaluate whether a safe plan can be created. This study by Edward Wang and Pencilla Lang used AI to predict SABR dose distributions for patients with multiple lung lesions...in under 3 minutes. 👇👇👇